ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab
Status:
Completed
Trial end date:
2017-09-25
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the efficacy observed with canakinumab dose
reduction in a subgroup of patients in the extension study CACZ885G2301E1.